The US National Institutes of Health has licensed rights to the drug cyclodextrin to Vtesse, a small biotech startup, to develop it as a treatment for Niemann-Pick Type C disease, reports Amy Dockser Marcus at the Wall Street Journal.
Registering provides access to this and other free content.
Already have an account?Login Now.
Using DNA to sketch crime victims might not be a great idea, the NYTimes says.
Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.
Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.
In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.